Cellerys AG
PrivateLast Round
Accelerator
Oct 1, 2015
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cellerys AG operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was an Accelerator round in October 2015.
Cellerys AG is a biotechnology company that develops immune tolerance therapeutics for the treatment of multiple sclerosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellerys AG Comparables
Compare Cellerys AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anokion | 89% | |
| Worg Pharmaceuticals | 79% | |
| Topas Therapeutics | 78% |
For institutional investors. Book with your work email.
Cellerys AG Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cellerys AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wyss Zurich | Accelerator |
| University of Zurich | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 187% MoM, reaching 1.2K.
- Jun 23, 2026
Monthly visitors grew 394% MoM, from 82 to 405.
For institutional investors. Book with your work email.
Cellerys AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellerys AG's valuation, stock price, and market status.
Is Cellerys AG a public or private company?
Cellerys AG is a private company.
What is the current stock price of Cellerys AG?
Cellerys AG is a private company, so its shares have no public market price. Caplight tracks Cellerys AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellerys AG worth (valuation)?
Valuation information for Cellerys AG is not publicly available.
Can I buy Cellerys AG stock?
Cellerys AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellerys AG's last funding round?
Cellerys AG's most recent funding round was Accelerator on October 1, 2015.
Who are the main investors in Cellerys AG?
Key investors in Cellerys AG include Wyss Zurich.
Will Cellerys AG IPO soon?
No public IPO plans have been announced for Cellerys AG.
How can I track Cellerys AG secondary market activity?
Caplight tracks bids, offers, and trades in Cellerys AG's shares on secondary markets.